NSAID-associated drug-induced liver injury prior to and following liver transplantation
Yıl: 2022 Cilt: 3 Sayı: 3 Sayfa Aralığı: 108 - 109 Metin Dili: İngilizce DOI: 10.14744/hf.2021.2021.0050 İndeks Tarihi: 22-05-2023
NSAID-associated drug-induced liver injury prior to and following liver transplantation
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010;16(45):5651-5661.
- 2. Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013;369(26):2525- 2534.
- 3. Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144(7):1419-1425, 1425.e1-3; quiz e19-20.
- 4. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, Gar- cía-Ruiz E, et al; Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences sub- mitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129(2):512-521.
- 5. Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis 2013;17(4):643-656, ix.
- 6. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf.2007;6(6):673-684.
- 7. Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010;138(7):2246-2259.
- 8. Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lu- cena MI, Andrade RJ. Drug induced liver injury: an update. Arch Toxicol 2020;94(10):3381-3407.
- 9. Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol 2015;63(2):503-514.
- 10. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:. EASL Clinical Prac- tice Guidelines: Drug-induced liver injury. J Hepatol 2019;70(6):1222- 1261.
| APA | GUMUSSOY M, GOKCAN H, BODAKCI E, KİREMİTCİ S, SAVAS B, IDILMAN R (2022). NSAID-associated drug-induced liver injury prior to and following liver transplantation. , 108 - 109. 10.14744/hf.2021.2021.0050 |
| Chicago | GUMUSSOY Mesut,GOKCAN Hale,BODAKCI Emin,KİREMİTCİ Saba,SAVAS Berna,IDILMAN Ramazan NSAID-associated drug-induced liver injury prior to and following liver transplantation. (2022): 108 - 109. 10.14744/hf.2021.2021.0050 |
| MLA | GUMUSSOY Mesut,GOKCAN Hale,BODAKCI Emin,KİREMİTCİ Saba,SAVAS Berna,IDILMAN Ramazan NSAID-associated drug-induced liver injury prior to and following liver transplantation. , 2022, ss.108 - 109. 10.14744/hf.2021.2021.0050 |
| AMA | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R NSAID-associated drug-induced liver injury prior to and following liver transplantation. . 2022; 108 - 109. 10.14744/hf.2021.2021.0050 |
| Vancouver | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R NSAID-associated drug-induced liver injury prior to and following liver transplantation. . 2022; 108 - 109. 10.14744/hf.2021.2021.0050 |
| IEEE | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R "NSAID-associated drug-induced liver injury prior to and following liver transplantation." , ss.108 - 109, 2022. 10.14744/hf.2021.2021.0050 |
| ISNAD | GUMUSSOY, Mesut vd. "NSAID-associated drug-induced liver injury prior to and following liver transplantation". (2022), 108-109. https://doi.org/10.14744/hf.2021.2021.0050 |
| APA | GUMUSSOY M, GOKCAN H, BODAKCI E, KİREMİTCİ S, SAVAS B, IDILMAN R (2022). NSAID-associated drug-induced liver injury prior to and following liver transplantation. Hepatology forum, 3(3), 108 - 109. 10.14744/hf.2021.2021.0050 |
| Chicago | GUMUSSOY Mesut,GOKCAN Hale,BODAKCI Emin,KİREMİTCİ Saba,SAVAS Berna,IDILMAN Ramazan NSAID-associated drug-induced liver injury prior to and following liver transplantation. Hepatology forum 3, no.3 (2022): 108 - 109. 10.14744/hf.2021.2021.0050 |
| MLA | GUMUSSOY Mesut,GOKCAN Hale,BODAKCI Emin,KİREMİTCİ Saba,SAVAS Berna,IDILMAN Ramazan NSAID-associated drug-induced liver injury prior to and following liver transplantation. Hepatology forum, vol.3, no.3, 2022, ss.108 - 109. 10.14744/hf.2021.2021.0050 |
| AMA | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R NSAID-associated drug-induced liver injury prior to and following liver transplantation. Hepatology forum. 2022; 3(3): 108 - 109. 10.14744/hf.2021.2021.0050 |
| Vancouver | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R NSAID-associated drug-induced liver injury prior to and following liver transplantation. Hepatology forum. 2022; 3(3): 108 - 109. 10.14744/hf.2021.2021.0050 |
| IEEE | GUMUSSOY M,GOKCAN H,BODAKCI E,KİREMİTCİ S,SAVAS B,IDILMAN R "NSAID-associated drug-induced liver injury prior to and following liver transplantation." Hepatology forum, 3, ss.108 - 109, 2022. 10.14744/hf.2021.2021.0050 |
| ISNAD | GUMUSSOY, Mesut vd. "NSAID-associated drug-induced liver injury prior to and following liver transplantation". Hepatology forum 3/3 (2022), 108-109. https://doi.org/10.14744/hf.2021.2021.0050 |
